Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion type Assertion NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_head.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion description "[The rate of HER2 gene amplification was significantly higher in type II EC compared with type I EC (17 vs 1%, P<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_provenance.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion evidence source_evidence_literature NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_provenance.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion SIO_000772 19088718 NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_provenance.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion wasDerivedFrom befree-20140225 NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_provenance.
- NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_assertion wasGeneratedBy ECO_0000203 NP622033.RAZdeH1lFqyzGfImLxrdSkVw48Z-ZvJRudTU-5Y1zhzxo130_provenance.